2019 Global HIV/AIDS Molecular and Immunodiagnostics Market: Supplier Country Shares, Segmentation Forecasts--Blood Banks, Commercial Labs, Hospitals, Physician Offices, Public Health Labs
Summary
This 7-country report presents detailed analyses of the AIDS diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. For each country, the report provides test volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/ NAT, Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments:
- Hospitals
- Commercial/Private Laboratories
- Blood Banks
- Physician Offices
- Public Health Laboratories
For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of AIDS tests.
Highlights
- Provides scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses.
- Examines market applications of Molecular Diagnostics, Immunodiagnostics, IT and other emerging technologies.
- Reviews infectious disease testing analyzers marketed by Abbott, Beckman Coulter, bioMerieux, Ortho Clinical Diagnostics/J&J, Roche, Siemens, Tosoh and other suppliers.
- Profiles over 30 leading manufacturers and potential market entrants developing innovative technologies and products.
- Analyzes alternative market penetration strategies for suppliers.
- Provides scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses.
- Examines market applications of Molecular Diagnostics, Immunodiagnostics, IT and other emerging technologies.
- Reviews infectious disease testing analyzers marketed by Abbott, Beckman Coulter, bioMerieux, Ortho Clinical Diagnostics/J&J, Roche, Siemens, Tosoh and other suppliers.
- Profiles over 30 leading manufacturers and potential market entrants developing innovative technologies and products.
- Analyzes alternative market penetration strategies for suppliers.
- Provides scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses.
- Examines market applications of Molecular Diagnostics, Immunodiagnostics, IT and other emerging technologies.
- Reviews infectious disease testing analyzers marketed by Abbott, Beckman Coulter, bioMerieux, Ortho Clinical Diagnostics/J&J, Roche, Siemens, Tosoh and other suppliers.
- Profiles over 30 leading manufacturers and potential market entrants developing innovative technologies and products.
- Analyzes alternative market penetration strategies for suppliers.
- Provides scientific views on the definition, epidemiology and etiology of AIDS and other retroviruses.
- Examines market applications of Molecular Diagnostics, Immunodiagnostics, IT and other emerging technologies.
- Reviews infectious disease testing analyzers marketed by Abbott, Beckman Coulter, bioMerieux, Ortho Clinical Diagnostics/J&J, Roche, Siemens, Tosoh and other suppliers.
- Profiles over 30 leading manufacturers and potential market entrants developing innovative technologies and products.
- Analyzes alternative market penetration strategies for suppliers.
Methodology
The report is based on a combination of primary and secondary information sources, including proprietary database developed during the course of over 100 syndicated studies and numerous proprietary single-client assignments. The database contains information on companies, technologies, products and executives worldwide. Moreover, a comprehensive review of the product and financial literature, business and technical periodicals, and pertinent industry analyst reports was conducted.
Complete report $5,450. DataPack (test volumes, sales forecasts, supplier shares) $3,500.
Summary
This 7-country report presents detailed analyses of the AIDS diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. For each country, the report provides test volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/ NAT, Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments:
- Hospitals
- Commercial/Private Laboratories
- Blood Banks
- Physician Offices
- Public Health Laboratories
For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of AIDS tests.
Highlights
Methodology
The report is based on a combination of primary and secondary information sources, including proprietary database developed during the course of over 100 syndicated studies and numerous proprietary single-client assignments. The database contains information on companies, technologies, products and executives worldwide. Moreover, a comprehensive review of the product and financial literature, business and technical periodicals, and pertinent industry analyst reports was conducted.
Complete report $5,450. DataPack (test volumes, sales forecasts, supplier shares) $3,500.
Summary
This 7-country report presents detailed analyses of the AIDS diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. For each country, the report provides test volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/ NAT, Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments:
- Hospitals
- Commercial/Private Laboratories
- Blood Banks
- Physician Offices
- Public Health Laboratories
For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of AIDS tests.
Highlights
Methodology
The report is based on a combination of primary and secondary information sources, including proprietary database developed during the course of over 100 syndicated studies and numerous proprietary single-client assignments. The database contains information on companies, technologies, products and executives worldwide. Moreover, a comprehensive review of the product and financial literature, business and technical periodicals, and pertinent industry analyst reports was conducted.
Complete report $5,450. DataPack (test volumes, sales forecasts, supplier shares) $3,500.
Summary
This 7-country report presents detailed analyses of the AIDS diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. For each country, the report provides test volume and sales forecasts for HIV/HIV-1/2/Combo, HIVAg/ NAT, Western Blot, HTLV-I/II and other confirmatory tests performed in the following market segments:
- Hospitals
- Commercial/Private Laboratories
- Blood Banks
- Physician Offices
- Public Health Laboratories
For each country, in addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of AIDS tests.
Highlights
Methodology
The report is based on a combination of primary and secondary information sources, including proprietary database developed during the course of over 100 syndicated studies and numerous proprietary single-client assignments. The database contains information on companies, technologies, products and executives worldwide. Moreover, a comprehensive review of the product and financial literature, business and technical periodicals, and pertinent industry analyst reports was conducted.
I. Introduction
II. Worldwide Test Overview,
Technologies and Instrumentation
A. Background, Diagnostic Tests, Vaccines and Drugs
B. Instrumentation Review: Operating Characteristics,
Features and Selling Princes of Leading Infectious Disease
Automated and Semi-automated Analyzers
C. Emerging Infectious Disease Diagnostic Technologies
1. Molecular Diagnostics
2. Monoclonal Antibodies
3. Immunoassays
4. Differential Light Scattering
5. Information Technology
6. Artificial Intelligence
7. Liposomes
8. Flow Cytometry
9. Chromatography
10. Diagnostic Imaging
11. Gel Microdroplets
12. Others
D. Personal Testing
III. Country Analyses: Sales and Volume Forecasts
IV. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
V. Design Criteria for Decentralized Testing Products
VI. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for Decentralized Testing Markets
VII. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges
VIII. Competitive Assessments
- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix/Erba
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher/Life Technology
- Wallac/PE
- Wako
2020 Germany Microbiology Lab and POC Market for 100 Tests: Supplier Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers, 2019-2023
This presents a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key German market trends; reviews
View Report2020 France Microbiology Lab and POC Market for 100 Tests: Supplier Shares, Segmentation Forecasts, Competitive Landscape, Innovative Technologies, Latest Instrumentation, Opportunities for Suppliers, 2019-2023
This presents a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years. The report examines key French market trends; reviews
View Report2020 Global HIV/AIDS Diagnostics Market: US, Europe, Japan--Supplier Shares, Volume and Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies
The report presents a detailed analysis of the AIDS diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the definition, epidemiology and
View ReportH2 2019 Global Petrochemicals Capacity and Capital Expenditure Outlook - China Leads Global Petrochemical Capacity Additions
H2 2019 Global Petrochemicals Capacity and Capital Expenditure Outlook - China Leads Global Petrochemical Capacity AdditionsGlobal petrochemicals capacity is expected to experience considerable growth over the next nine years from
View ReportFill The Form For Sample Request